Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease.
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease.
复制标题
DOI:
10.1038/s41467-018-07466-6
复制
发表时间:
2018-11-29
影响因子:
16.6
通讯作者:
Dor Y
中科院分区:
文献类型:
--
作者:
Moss J;Magenheim J;Neiman D;Zemmour H;Loyfer N;Korach A;Samet Y;Maoz M;Druid H;Arner P;Fu KY;Kiss E;Spalding KL;Landesberg G;Zick A;Grinshpun A;Shapiro AMJ;Grompe M;Wittenberg AD;Glaser B;Shemer R;Kaplan T;Dor Y
Methylation patterns of circulating cell-free DNA (cfDNA) contain rich information about recent cell death events in the body. Here, we present an approach for unbiased determination of the tissue origins of cfDNA, using a reference methylation atlas of 25 human tissues and cell types. The method is validated using in silico simulations as well as in vitro mixes of DNA from different tissue sources at known proportions. We show that plasma cfDNA of healthy donors originates from white blood cells (55%), erythrocyte progenitors (30%), vascular endothelial cells (10%) and hepatocytes (1%). Deconvolution of cfDNA from patients reveals tissue contributions that agree with clinical findings in sepsis, islet transplantation, cancer of the colon, lung, breast and prostate, and cancer of unknown primary. We propose a procedure which can be easily adapted to study the cellular contributors to cfDNA in many settings, opening a broad window into healthy and pathologic human tissue dynamics. The methylation status of circulating cell-free DNA (cfDNA) can be informative about recent cell death events. Here the authors present an approach to determine the tissue origins of cfDNA, using a reference methylation atlas of 25 human tissues and cell types, and find that cfDNA from patients reveals tissue contributions that agree with clinical findings.
登录
查看更多内容
影响因子:
17.1
作者:
De Vlaminck I;Valantine HA;Snyder TM;Strehl C;Cohen G;Luikart H;Neff NF;Okamoto J;Bernstein D;Weisshaar D;Quake SR;Khush KK
通讯作者:
Khush KK
影响因子:
14.9
作者:
Li W;Li Q;Kang S;Same M;Zhou Y;Sun C;Liu CC;Matsuoka L;Sher L;Wong WH;Alber F;Zhou XJ
通讯作者:
Zhou XJ
DOI:
10.1186/cc11466
发表时间:
2012-08-13
期刊:
Critical care (London, England)
影响因子:
--
作者:
Dwivedi DJ;Toltl LJ;Swystun LL;Pogue J;Liaw KL;Weitz JI;Cook DJ;Fox-Robichaud AE;Liaw PC;Canadian Critical Care Translational Biology Group
通讯作者:
Canadian Critical Care Translational Biology Group
影响因子:
29.4
作者:
Duncan AW;Hanlon Newell AE;Smith L;Wilson EM;Olson SB;Thayer MJ;Strom SC;Grompe M
通讯作者:
Grompe M
影响因子:
64.8
作者:
Abbosh C;Birkbak NJ;Wilson GA;Jamal-Hanjani M;Constantin T;Salari R;Le Quesne J;Moore DA;Veeriah S;Rosenthal R;Marafioti T;Kirkizlar E;Watkins TBK;McGranahan N;Ward S;Martinson L;Riley J;Fraioli F;Al Bakir M;Grönroos E;Zambrana F;Endozo R;Bi WL;Fennessy FM;Sponer N;Johnson D;Laycock J;Shafi S;Czyzewska-Khan J;Rowan A;Chambers T;Matthews N;Turajlic S;Hiley C;Lee SM;Forster MD;Ahmad T;Falzon M;Borg E;Lawrence D;Hayward M;Kolvekar S;Panagiotopoulos N;Janes SM;Thakrar R;Ahmed A;Blackhall F;Summers Y;Hafez D;Naik A;Ganguly A;Kareht S;Shah R;Joseph L;Marie Quinn A;Crosbie PA;Naidu B;Middleton G;Langman G;Trotter S;Nicolson M;Remmen H;Kerr K;Chetty M;Gomersall L;Fennell DA;Nakas A;Rathinam S;Anand G;Khan S;Russell P;Ezhil V;Ismail B;Irvin-Sellers M;Prakash V;Lester JF;Kornaszewska M;Attanoos R;Adams H;Davies H;Oukrif D;Akarca AU;Hartley JA;Lowe HL;Lock S;Iles N;Bell H;Ngai Y;Elgar G;Szallasi Z;Schwarz RF;Herrero J;Stewart A;Quezada SA;Peggs KS;Van Loo P;Dive C;Lin CJ;Rabinowitz M;Aerts HJWL;Hackshaw A;Shaw JA;Zimmermann BG;TRACERx consortium;PEACE consortium;Swanton C
通讯作者:
Swanton C